GSTM1 and cancer: In the realm of cancer research, the Hb/RDW ratio emerges as a pivotal biomarker that was initially proposed as a prognostic indicator in esophageal squamous-cell carcinoma (ESCC) [23] and subsequently applied across diverse cancer types [34,42,43].